Stay updated with breaking news from Partd Redesign. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On the one-year anniversary of the IRA’s signing, most of the bill’s impact on drug prices and Medicare beneficiary out-of-pocket spending has yet to be determined.
On May 12, 2023, the Centers for Medicare & Medicaid Services (CMS) issued Draft Guidance on the Part D Manufacturer Discount Program (“Discount Program”)—a key component of the Part D...
The Inflation Reduction Act of 2022 (the Act) includes prescription drug provisions that have significant implications for the pharmaceutical industry and Medicare beneficiaries, such...